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Induction of LFA-1 on Pluripotent CD34+ Bone Marrow Cells Does Not 
Affect Lineage Commitment
By Ruurd Torensma, Reinier A.P. Raymakers, Yvette van Kooyk, and Carl G. Figdor
Leukocyte function associated antigen 1 (LFA-1) is an adhe­
sion molecule indispensable in immune and inflammatory 
reactions, but its role in hematopoiesis remains obscure. 
Since LFA-1 is predominantly expressed by leukocytes, it is 
considered as a marker of late stage stem cell maturation 
when expressed on CD34+ bone marrow cells, and repre­
sents more mature hematopoietic progenitor cells. We ob­
served that freshly isolated CD34+ bone marrow cells ex­
press LFA-1, and that the level of expression is highly 
variable. Interestingly, the expression of the LFA-1 specific 
activation epitope L16 on these cells is low, even after cul­
ture. This demonstrates that LFA-1 is not activated, as was 
confirmed by low adhesion to ICAM-1. Culturing sorted 
CD34+LFA-1+ cells in single cell per well assays in medium 
supplemented with SCF, Epo, IL-3, IL-6, GM-CSF, and G-CSF 
revealed that they gave rise to dispersed macrophage-like 
colonies, supporting the notion that CD34+LFA-1 + cells in­
deed consist of a mature committed cell population. In con­
trast, sorted CD34+LFA-1-  cells had high proliferative poten­
tial and developed into large multilineage colonies within 
14 days of culture. Unanticipated, in time course experi­
ments we observed that these CD34+LFA-1~ cells expressed 
LFA-1 within 24 hours upon culture. This induction was nei­
ther caused by the monoclonal antibody used to tag CD34 
cells, nor dependent on growth factors present in the me­
dium. These findings demonstrate that two populations of 
CD34+LFA~1+ cells can be discriminated: leukocyte lineage 
committed CD34+ cells in freshly isolated bone marrow cells, 
and multipotent CD34+ cells that acquired LFA-1 upon in 
vitro culture. These in vitro findings support the hypothesis 
that once contacts with bone marrow stroma are lost, LFA- 
1 is upregulated by default, due to the lack of negative regu­
lating signals from stromal cells. This might also explain the 
widely variable expression of LFA-1 as a result of crowding 
of cells in the bone marrow with subsequent loss of contact 
with stroma and upregulation of LFA-1, providing those cells 
with adhesion receptors enabling migration in the periphery. 
© 1996 by The American Society of Hematology.
ORMAL HEMATOPOIESIS occurs in the bone mar­
row and is controlled by the marrow micro environ­
ment.1'3 Regulation of hematopoiesis is mediated by cellular 
interactions through adhesion molecules, cytokines, chemo- 
tactic factors, and the extracellular matrix.4"10 Bone marrow 
stroma cells consist of several different cell types that play 
an important regulatory role in hematopoiesis, and the 
growth and differentiation of bone marrow stem cells and 
progenitor cells.11,12 Besides growth and differentiation, he­
matopoiesis also comprises stem cell renewal to maintain a 
certain level of pluripotent stem cells. The pathways that 
control growth and differentiation on the one hand, and self 
renewal on the other hand are largely unknown. Growth 
promoting signals for early hematopoietic cells are provided 
by several cytokines produced by stromal cells4'13; however,
growth inhibiting cytokines have also been reported. 14» 16 The
interplay between growth promoting and inhibiting modula­
tors is likely to be coordinated by dynamic interactions of 
stromal cells with hematopoietic cells. The signalling mole­
cules involved in growth promoting and self-renewal are 
largely unknown.17
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In addition to growth inhibiting and stimulating soluble 
factors produced by stroma cells, part of the processes that 
control hematopoiesis is provided by native associations of 
early progenitor cells and stromal cells. In those aggregates, 
cells pass through definite stages of development.3,5 Adhe­
sion of early hematopoietic cells to stromal elements is medi­
ated by a number of adhesion molecules, in particular by 
several members of the /31-18'21 as well as the ¡32-~2 integrin 
family. Mobilization of hematopoietic progenitors into the 
bloodstream upon treatment of primates with antibodies to 
the (51 -integrin receptor very late antigen (VLA)-4, CD49d/ 
CD29,23 and disruption of the aggregates of hematopoietic 
cells with stromal cells by antibodies directed to VCAM-1, 
the ligand of VLA-4,5 demonstrated the role of those mem­
bers of the /31-integrins in interactions between hematopoi­
etic and stromal cells. Downregulation of VLA-4 and 
VLA-5 (CD49a/CD29) was observed during maturation of 
granulocytes resulting in mobilization of these cells into the 
periphery,24 and during myeloid differentiation, the expres­
sion of VLA-4 and VLA-5 was lost.25,20 These studies indi­
cate the prominent role of these /? 1 -integrins in lodging of
4
early hematopoietic cells.
The role of the /?2-inlegrins is, however, less well under­
stood. Although (52-integrins probably are not likely in­
volved in maintaining the association of hematopoietic cells 
with the stroma,27 since antibodies directed to /32-integrins 
were unable to mobilize progenitors into the bloodstream, 
recent data showed the interaction of /32-integrins with its 
ligands are involved in several cell-cell adhesion and signal­
ing processes,2y,3° as well as in the production of growth 
inhibiting cytokines.31 Recent evidence showed that the /32- 
integrin pathway is activated by signals mediated by CD34, 
resulting in enhanced homotypic cell adhesion.32,33 In this 
study we performed a detailed analysis of individual 
CD34+LFA-1~ and CD34+LFA-1+ cells to establish the po­
tential role of LFA-1 on growth and differentiation of CD34+ 
bone marrow cells. In this analysis we included expression 
of the LFA-1 activation epitope L I6, which is a marker for
4120 Blood, Vol 87, No 10 (May 15), 1996: pp 4120-4128
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Fig 1. Percentage of CD34+LFA+ cells in normal bone marrow of 
18 individual donors with a mean of 33%.
a clustered distribution of LFA-1, a prerequisite for strong 
adhesion.34,35 The results demonstrate that LFA-1 was ex­
pressed on part of freshly isolated CD34+ cells in an inactive 
state and coincided with a mature progenitor cell population.
Interestingly, CD34+LFA-1~ cells acquire LFA-1 during in 
vitro culture, but despite this upregulation of LFA-1 in vitro, 
those cells still comprise a pluripotent cell population sug­
gesting that once microenvironmental factors are lacking 
LFA-1 is upregulated by default.
MATERIALS AND METHODS
Cells. Bone marrow (BM) cells were obtained from normal allo­
geneic BM donors after informed consent. BM was diluted with 
phosphate buffered saline (PBS) and mononuclear cells were isolated 
by Ficoll-Hypaque density centrifugation (specific gravity, 1.077).
After washing, the cells were rosetted with anti-CD34 monoclonal 
antibody (MoAb) coated magnetic beads (Dynal, Oslo, Norway) for 
60 minutes at 4°C with gentle rotation. CD34 positive cells were 
collected by magnetic force and subsequently released from the 
CD34 beads with DETACHaBEAD (Dynal). Isolated cells were free 
from beads and their purity exceeded 90% as determined with flow 
cytometric analysis. Batches of 200,000 CD34 positive cells were 
frozen and stored in liquid nitrogen until use.
Staining with MoAb. CD34+ cells were thawed and subsequently 
washed with PBS. The pelleted cells were suspended in 50 ¡xL PBS 
containing 10% normal human serum. Appropriate dilutions of the 
MoAbs (anti-CD34 labeled with phycoerythrin: HPCA-2; Becton 
Dickinson, San Jose, CA; anti-LFA-1 labeled with FITC: SPV-17, 
directed to the a L  chain of LFA-136; NKI-L16, directed to an activa­
tion epitope on the aL  chain of LFA-134) were added. For determin­
ing L16 expression, cells were suspended in 50 ¡ jlL  PBS containing 
10% normal mouse serum treated with Chelex-100 (Biorad, Rich­
mond, CA) to remove divalent cations. Incubations with control 
antibodies labeled with either FITC or phycoerythrin were run in 
parallel. Cells were incubated with the MoAbs for 45 minutes at 
0°C. After washing in PBS the cells were suspended in 1 mL PBS 
and used for cell sorting.
Cell sorting. Dual color membrane immunofluorescence was 
performed by simultaneous labeling with FITC and PE labeled 
MoAbs. Fluorescence was analyzed using a Coulter Epics Elite 
(Coulter, Hialeah, FL) flow cytometer with an argon laser tuned at 
488 nm. Lighl-scatter was set such to exclude subcellular particles 
and dead cells. Single cells positive for CD34 and either positive or 
negative for LFA-1 were sorted in a round bottom 96-well plate 
(Costar, Cambridge, MA) using an autoclone device.
Culture of the sorted cells. Sorted cells were cultured in Iscove’s 
Modified Dulbecco’s Medium (IMDM) containing IL-3 (50 ng/mL),
GM-CSF (20 ng/mL), G-CSF (20 ng/mL), SCF (25 ng/mL), EPO 
(2 U/mL), IL-6 (10 ng/mL), transferrin (300 ¿ig/mL), bovine serum 
albumin (7.5 ¿¿g/mL), /3-mercaptoethanol (20 ¿¿mol/L), and 20% 
fetal calf serum (FCS; Hyclone, Logan, UT) and incubated at 37°C 
in a fully humidified atmosphere containing 5% C 0 2.
Monitoring of cell growth. Twice a week the individual wells 
were monitored with an inverted microscope using pseudo-phase 
contrast illumination and equipped with a camera. The video images 
were analyzed using a dedicated cell recognition software package.
The package and its use in hematopoiesis is described in detail 
elsewhere (Boezeman et al, submitted). The cell counts as analyzed 
by the program were stored in a spreadsheet allowing the construc­
tion of growth curves. In addition, all video images of the individual 
wells were stored on disk. This image was used to verify the analysis 
by the program. Growth was monitored using three categories: 1,
>  1,000 cells; 2, >  100 cells but <  1,000 cells; 3, <  100 cells but more 
than 2 cells. To correct for different plating efficiencies obtained with fluorescence obtained  w ith  control an tibodies (frame 2), and
the individual donors, growth was expressed as the ratio between 
the number of wells belonging to one category and the total number 
of wells containing growing cells.
Induction of LFA-1. Frozen CD34+ cells that were isolated im- 
munomagnetically were thawed and labeled with CD34-PE and 
LFA-1-FITC. The CD34+/L F A -r  cells were sorted into a 24-well 
plate at a density of 10,000 cells per well. The cells were cultured 
over 48 hours in IMDM medium containing 10% FCS. The cells 
were collected and stained with CD34-PE and LFA-1-FITC. Single 
LFA-1 positive and negative cells were sorted in a 96-well plate 
containing IMDM medium and growth factors and growth was re­
corded over 14 days.
Phenotypic analysis of growing colonies. Nine days after initiat­
ing the single cell per well culture the growing cells were collected 
and stained with Glycophorin-PE (Immunotech, Marseille, France) 
CD15-PE and CD 14-FITC (Becton Dickinson, San Jose, CA) to 
establish putative multilineage potential.
Adhesion assays. Cells were isolated from freshly collected nor­
mal. bone marrow and subsequently sorted into a CD34+/LFA-1~ and 
a CD34'7LFA- l + population. Part of those cells was used directly in 
adhesion assays while the remaining cells were cultured for 2 days 
before the adhesion assays were performed. ICAM-1 fusion protein 
consisting of the five extracellular domains of ICAM-1 fused to a 
human IgG I Fc fragment was used in the adhesion assays. Twenty 
thousand sorted cells were added to immobilized ICAM-1 Fc chime­
ric protein and incubated for 30 minutes at 37°C. After washing, the 
number of adhered cells were determined. Adhesion properties of 
activated LFA-1 were deduced from assays in which 50 nmoI/L 
PMA was added during incubation.
RESULTS
Expression o f LFA-1 by CD34 positive cells. The results 
in Fig 1 demonstrate that the expression of LFA-1 on CD34 
positive cells was highly variable as found for 18 different 
donors. The percentage LFA-1 positive cells ranged from 
5% to 70% with a mean of 33%. No correlation with the 
age of the donor was found. The LFA-1 and CD34 double 
staining fluorescence pattern is shown in Fig 2. The upper 
row shows the forward and side scatter (frame 1), double
4122 TORENSMA ET AL
Donor 1
* m " s ' * ■ »-1-^0>
«M(Q
Ot/>
"O
Utm
Eo11
» •  -4 —•
T
scatter
LU
CL
r.i *  » I « •  *  • I I #  » >—*• * » *  •
X
~ W , * '—P .‘ 4 ‘ '.*4 TE®**-*/&\%lrEú Í 
p '**’ •< *■* *. * •
L  « i » » l i  S . v  » « i• ’ Vi  *>f,V*P’*' *yV ■ 
I l  s  >  * *  *  V  j  * ! » • » ■  .
»  i  * ‘  * ♦♦ "v •>*?».*k i  t  > ( 4
>  * i  *  ' *  .  .  I  » » . .f it ltT i
i •. • .  «  * 't  >. M i
A
2
tinmr -T T itm n  —r fttiiti
i g G i FITC
UJ
CL
COao
i m . m i«
9%
4
~ t tìTfmr t  niTìf —t n in n i *t rrm n l
LFA-1 FITC
Donor 2
0)
nio</>
TJ
t i H
r e
o
UL
JP x r v  r< , »  » 0  t «1* p« v  '■» M * * l<  t  t H '  I  *»> - «W 4^
• I
V J l  %■ , ♦ •  ► * ♦ >  , K$%#*!*;■ ' <•*: r *• •
♦ -S' li Vi • •
Side scatter
*>
LU
CL
CDo>
1
* w h
» • i  »• » i  i a I t i  1 - ,  • i j  i • «
c
s
r im im - r im m r  ~ r rn tn i
ig G - i FITC
UJn
COQU
.'1 * ♦ * ►
1
«  * * i r
'i 'i
. 1 ’ ' *  *
‘  'vi
* t
■ » ■
V TÌfTTÌTT
■ 1 '  *
D
70%
.V i k- •
-i* ,
• ‘ » V  V *  *  *
V
♦  ’
p¿* Sl'fep5:*:i* "V
•» » £ *
>» . » ■  I l  > w
r m i n r ^ f t  trThn—  r r  tttui
LFA-1 FITC
Fig 2. LFA-1 expression on 
isolated CD34 positive bone 
marrow cells. Cells were labeled 
with CD34-PE and L7-FITC. Incu­
bations with irrelevant MoAbs 
were used to set the gates in 
such a way that less than 1% of 
these cells are positive. (A) Do­
nor with low LFA-1 expression. 
<B) Donor with high LFA-1 ex­
pression.
double fluorescence obtained with LFA-1-FITC and CD34- 
PE antibodies (frame 3). Staining for LFA-1 expression was 
generally dim as exemplified in the upper panel of Fig 2. 
The lower row shows the results obtained with a different 
donor. Furthermore, CD34+ cells lacked expression of the 
L I6 activation epitope demonstrating the expression of an 
inactive form of LFA-1 (data not shown).
Growth characteristics o f LFA-1 positive and negative 
cells. LFA-1 expression was found to correlate to more 
mature progenitor cells when cultured on allogeneic stromal
37 To gain insight into possible effects of the stromal 
layer on the growth characteristics, single CD34+LFA-1+ as 
well as CD34''LFA-1 cells were cultured for 14 days in
containing several cytokines. From 
growth curve (Fig 3), it is concluded that the majority of the
CD34 LFA-1 ~ cells grew rapidly with a doubling time of 
approximately 24 hours. The same growth characteristics 
were found for five individual donors. The growth potential 
of the CD34+LFA-l+ cells was much less. After reaching 
50 to 100 cells the cells stopped growing any further. Further 
analysis demonstrated that the majority of the CD34+LFA- 
1 cells belong to the category representing the largest col­
ony size (Fig 4). On the contrary, the majority of the 
CD34+LFA-1+ cells belong to the category that grows to 
less than 100 cells (Fig 4).
Morphology o f the growing cells. Because LFA-1 has 
been implicated in lineage commitment, the morphology of 
both CD341 LFA-1 and CD34+LFA-1+ colonies was noted 
using the video image. CD34+ cells that do not express LFA- 
1 grew to be very large colonies (>1,000 cells). However,
Fig 3. Growth curves of cells seeded in eight con­
secutive wells of a 96-well plate. Note that the 
growth potential of the LFA-14 cells was less than 
that of the LFA-1" cells.
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Fig 4. Growth of CD34 posi­
tive bone marrow cells. Cells 
were sorted based on their LFA- 
1 expression. Growth was 
scored as the highest number of 
cells obtained during 14 days of 
culture in medium containing cy­
tokines, Three categories were 
defined: 1, colonies containing
more than 1,000 cells {¡SJ); 2, col­
onies containing more than 100 
but less than 1,000 cells (O); and 
3, colonies containing less than 
100 cells (□). The results for the 
different categories were ex­
pressed as a percentage of the 
total number of wells containing 
growing cells.
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different sizes were noted us exemplified by the upper row of adhesion molecules). Furthermore, to exclude that MoAbs 
Fig 5. Erythroid, granulocytic, monocytic, as well as mixed against CD34 used to isolate the cells induced LFA-1 expres- 
colonies were found as deduced from staining pooled colo- sion,32,3'1 we labeled freshly isolated bone marrow cells with 
nies with MoAbs directed to glycophorin A, CD15, and anti-LFA-1 antibodies and sorted the LFA-1 negative frac­
tion. After culturing for 48 hours, the LFA-1 expression on 
the CD34+ subpopulation was determined after staining with
CD 14. A completely different picture was seen when analyz­
ing the LFA-1 1 cells. The size of these colonies was very 
small. The majority of the cells grew to be less than 100 anti-CD34 antibodies. LFA-1 expression on these cells was 
cells. The cells were dispersed throughout the well and had comparable with cells from the same donor obtained after
48 hours culture initiated with CD34+LFA-1 “ cells. Thesean irregular appearance, resembling macrophages (Fig 5, 
lower row). Essentially, the same growth pattern was ob­
served lor all tested donors.
Induction o f LFA-1 during culture.
findings demonstrate that induction of LFA-1 is not due to 
prior labeling with CD34 antibodies.
we investigi Expression of the L I6 epitope adhesion of
expressing CD34* cells. The activation status of LFA-1 
expressed on CD344 cells was deduced from staining with 
MoAb NK1-L16. The results are shown in Table 1. CD34+ 
cells cultured for 48 hours in medium were regarded as 
L 16'° suggesting they express an inactive form of LFA-1.
whether in vitro culture affected LFA-1 expression. CD34' 
cells were stained with an antibody directed toward LFA-1, 
and subsequently the LFA-1 negative cells sorted in a 24- 
well plate. Surprisingly, (lie majority of the cells acquired 
LFA-1 expression during culture for 48 hours. The level of 
induced expression of LFA-1 was variable (data not shown).
Up to 90% of the CD34 'LFA-1 cells acquired LFA-1 dur­
ing culture. To investigate whether induction of LFA-1 is 
caused by
CD34' LFA-1 cells in the presence and absence of growth 
factors. Essentially the same results were observed (Fig 6). demonstrated by adhesion assays in the presence of PMA 
These findings suggest that induction of LFA-1 is likely due (Fig 7). For both cell populations adhesion was clearly dem- 
to the lack of factors provided by the stroma (soluble factors, onstrated. Adhesion of resting PBL to ICAM-1 is also indi-
, we
, hardly any adhesion was found for CD34 LFA- 
1+ ceils to 1CAM-J. The CD34; LFA-1 cells that became 
partially LFA-1 positive during culture for 48 hours showed 
hardly any adhesion to ICAM-1. In accordance those cells 
are L 16'° (Table 1). The functional capability of LFA-1 was
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Fig 5. or CD34+LFA-1+ bone marrow
cated in Fig 7. Freshly isolated PBL express an inactive 
form of LFA-1.35 CD34+ cells display the same adhesion 
properties as resting PBL. It can be concluded that LFA-1
1“ cells acquired LFA-1 expression in culture, large dif­
ferences in growth characteristics between LFA-1+ and 
LFA-1" cells were observed, indicating that induction of
on CD34 cells is expressed in an inactive form and that this LFA-1 does not coincide with lineage commitment. There-
does not change during in vitro culture.
Comparison o f growth properties o f cells that do or do 
not acquire LFA-1 expression in culture. Although LFA-
§
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Fig 6. LFA-1 expression on freshly sorted CD34+LFA-1~ after in 
vitro culture. Every 24 hours a sample was collected and the LFA-1 
expression measured. Cells were plated in medium containing 10% 
FCS (■). After 24 hours of culture in medium containing growth fac­
tors, cells were harvested and plated in medium with 10% FCS (♦) .
fore, CD34+LFA-1~ cells were sorted and cultured for 48 
hours. Subsequently, the cells were harvested and after stain­
ing with an anti-LFA-1 MoAb sorted to follow the progeny 
of single cells. We noticed that the growth capacity of cells 
that acquire LFA-1 expression in vitro is much larger than 
cells that remain LFA-1 negative (Fig 8). In both cases, the 
obtained colonies comprised granulocytic, monocytic, and 
erythroid cells as deduced from light microscopy, indicating 
their multilineage properties. To support this visual observa­
tion, cells were collected after 9 days of culture and stained 
with Glycophorin-PE, CD14-PE, and CDI5-FITC. The re-
are depicted in Fig 9. Scatter analysis indicated that
Table 1. Expression of LFA-1 and Its Activation Epitope NKI-L 16 by
Cultured CD341 Cells
CD34*LFA-r CD34*LFA-1
Control 2 (190) 1 (134)
L7 88 (462) 34 (228)
L16 23 (289) 21 (205)
Mononuclear bone marrow cells were sorted into a CD34* LFA-1 * 
and CD34'LFA-1- fraction and cultured for 2 days. Collected cells 
were stained for the indicated MoAbs. The percentage positive ceils 
are presented and the mean fluorescence channel is indicated in pa­
rentheses.
INDUCTION OF LFA-1 ON CD341 CELLS
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Fig 7. Adhesion of freshly isolated and sorted 
CD34 ^LFA*1 and CD34 * LFA-11 and cells cultured for 
48 hours to ICAM-1» Adhesion assays in the presence 
of SO nmoI/L PMA were run in parallel* For compari­
son the adhesion of freshly isolated normal PBL is  
depicted. Adhesion assays using LFA-1 cells in the 
presence of PMA were not performed. * ,  cells that 
were LFA-1 at the start of the culture and became 
partially LFA-1* during culture.
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the I .FA-1 
ter than the
at remain negative showed less side scat- CD344LFA-r*' in single cell per well assays support and
at became LFA-1 indicating more mu- finding. Here, we also demonstrate that
hire myeloid cells in the subpopulation that acquired LFA- CD34+LFA-1~ bone marrow cells become LFA-1+ after in
1 expression. From the staining with MoAbs it is evident 
that both cell populations contained erythroid, myeloid, and 
granulocytic cells, demonstrating that this in vitro induced 
LFA-1 expression is not linked to lineage commitment.
DISCUSSION
The expression of LFA-1 coincided with more mature
C f marrow cells as
capacity of sorted cells on ü 
‘•'s.'7 The data obtained in
from colony forming 
aic irradiated stromal lay-
with sorted
LFA-1~/ +
LFA-1 - / 4 .
LFA-1
80
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vitro culture. Notwithstanding, this upregulation of LFA- 
1 cultures initiated with CD34+LFA-1~ bone marrow cells 
contained colonies of several lineages. In both populations 
CD15+, CD14+, CD14+CD15+, and glycophorin+ cells were 
detectable, indicating the multilineage potential of both sub­
populations.
It is remarkable that LFA-1 is not activated since expres­
sion of the LFA-1 activation epitope L16 was low. This 
indicates that LFA-1 is not likely to be involved in strong 
binding of the hematopoietic cells to the stroma. This is in 
accordance with mobilization data in which MoAbs toward 
LFA-1 were unable to mobilize hematopoietic cells in con­
trast to anti-VLA-4 antibodies.23’28 Recently, it was reported 
that the [31 -integrins VLA-4 and VLA-5 are expressed on 
steady state bone marrow in a low affinity configuration 
that upon treatment with cytokines transiently increase their 
adhesive function.38 Similarly, the /32-integrin LFA-1 is also 
expressed on CD34+ bone marrow cells in a nonactivated 
form, but in addition, expression of LFA-1 is rapidly upregu- 
lated by in vitro culture independent from cytokine treat­
ment. It is tempting to speculate about the physiologic func­
tion in vivo of upregulation of LFA-1. We hypothesize that 
in steady state bone marrow LFA-1 is downregulated due to 
interactions with the stromal cells. During episodes in which 
the immune system is activated (ie, infection), a transient 
lowering of the ratio between growth inhibiting and growth 
stimulating cytokines will initiate cell proliferation, resulting 
in crowding of proliferating progenitor cells in the bone 
marrow. Therefore, significant numbers of cells will not be 
able to make firm contacts with the stroma since all space 
is already occupied. As a result, these cells will rapidly 
upregulate LFA-1, thus equipping these cells with surface 
molecules that allow migration into the periphery. Such a 
mechanism predicts that the percentage CD34h cells that
Fig 8. CD34fLFA-l cells were sorted and grown in medium con- express LFA-1 is highly variable. The wide variation in 
tainlng 10% FCS. After 48 hours of culture, cells were harvested and LFA-1 expression as was found here supports this hypothe-
eorted In single cell per well assays. Plating efficiency of CD34 cells 
that acquired LFA-1 (LFA-1 n ) and CD34 cells that remained LFA-1
negative (LFA-1 '  ) after 2 days of culture is shown. The results of 
two donors are shown.
sis. These data emphasize that not only activation, but also 
upregulation of adhesion molecules, plays an important role 
in maintaining normal steady state bone marrow. This notion
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Fig 9. Phenotypic analysis of 
CD34 cells recovered from single 
cell per well assays initiated 
with cells that acquired LFA-1 in 
culture (LFA-1-/+) or cells that 
remained LFA-1 negative (LFA- 
1_/”). The cells were harvested 
and stained for Glycophorin-PE, 
CD14-PE, and CD15-FITC.
is supported by Mullersieburg and Deryugina, who sug­
gested a similar mechanising 
It was reported earlier that LFA-1 expressing CD34 positive
■37 Indeed, we
populations. This is different from the results obtained with 
the LFA-1 positive cells.
Activation of LFA-1 and subsequent adhesion is a 
multistep process. The expression of the L16 epitope is an 
important step in this process.35 Lack of L I6 expression in 
CD34+ bone marrow cells indicates that LFA-1 is not ac­
tively involved in adhesion. Expression of LFA-1 is neces­
sary to enable LFA-1 mediated migration. At the migration
M
site LFA-1 will be activated. Hence, LI 6 expression will be 
low and upregulated at the place of migration. Inactive LFA- 
1 was also found on KG1 cells. On those cells, LFA-1 medi­
ated adhesion was induced by signals mediated by CD34.'12,33 
The expression of LFA-1 on CD341 bone marrow cells 
CD34+LFA-1 ~ cells and hence our CD 18'" fraction contained as reported here is significantly lower compared with data 
CD341 progenitors. Others found that upon culturing of CD34 by others.27,43,44 In the context of the present findings, this
s comprised a more mature progenitor s 
show here that this subset is largely committed to the macro­
phage lineage based on the growth potential of single CD34 
positive cells. Recently it was described that the LFA-1 positive 
precursors isolated from fetal liver contained all progenitor 
types, whereas LFA-1 negative cells contained only erythroid 
progenitors.'10 However, at that stage erythropoiesis is predomi­
nant and granulomonocytopoiesis is minimal. Moreover, their 
CD 18 nonadherent fraction did not express CD34 explaining 
the low progenitor content. We sorted CD34+LFA-1+ and
positive cells, the expression of LFA-1 diminishes after 15 days 
of culture.41 This indicates again that the expression of LFA-1 
is not linked to the differentiation state of the bone marrow 
cells, since upon culture cells become more mature. Lack of 
linkage between the expression of surface molecules and differ­
entiation was recently also observed for DR expression on 
primitive cells.42
The extremely rapid upregulation of LFA-1 in vitro high­
lights the dynamic behavior of CD34 positive cells when 
placed outside the microenvironment of the bone marrow. 
Cells that acquire LFA-1 in vitro showed a higher plating 
efficiency than the cells that remained LFA-1 negative. No 
commitment to a certain lineage was observed for both sub­
discrepancy in expression is likely due to differences in iso­
lation procedure of the CD34 positive cells. We isolated the 
CD34 positive cells by means of magnetic bead isolation, 
and the collected cells were frozen immediately after isola­
tion. Such an isolation procedure is completed within 5 hours 
after collecting the bone marrow and is largely performed 
at 0°C. Labeling experiments were performed directly after 
thawing of the cells. This is different from other reports in
which the isolated CD34 cells were incubated for at least 24 
hours in medium containing serum at 37°C before analyzing 
LFA-1 expression.27,45 Culturing of these cells in the pres­
ence of IL-3 further increased the expression of LFA-1.45 
This indicates that the higher level of LFA-1 expression, as
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was reported earlier, is at least partially due to this rapid
induction in vitro.
14. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJ: 
Macrophage-inflammatory protein protects multipoteiU hematopoi-
In conclusion, we found that CD34 positive cells showed etic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 
variable expression of LFA-1, and that the expression of 79:2605, 1992
15. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beck­
mann MP, Cerami A, Ralph P: Comparative analysis of the human 
macrophage inflammatory protein family of cytokines (chemokines) 
on proliferation of human myeloid progenitor cells. Interacting ef­
fects involving suppression, synergistic suppression, and blocking 
of suppression. J Immunol 150:3448, 1993
LFA-1 does not play a pivotal role in adhesion of hematopoi- 16. Lu L, Xiao M, Grigsby S, Wang WX, Wu B, Shen RN, 
etic cells  to the bone marrow matrix but rather prepares cells Broxmeyer HE: Comparative effects of suppressive cytokines on
LFA-1 coincides to a mature lineage committed cell popula­
tion. Moreover, LFA-1 is present in an inactive state. Fur­
thermore, upon initial in vitro culturing, LFA-1 negative 
cells rapidly obtain LFA-1, but no induction of lineage com­
mitment was -sc observations indicate that
for their life in the periphery. It will be extremely interesting isolated single CD34(3+) stem/progenitor cells from human bone
marrow and umbilical corcl blood plated with and without serum. 
Exp I-Iematol 21:1442, 1993
17. Steinlein P, Wessely O, Meyer S, Deiner E-M, Hayman MJ,
to identity the elements (soluble factors, adhesion molecules) 
that suppress LFA-1 expression in the bone marrow.
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